KYTHERA BIOPHARMACEUTICALS INC
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY14 | FY13 | FY12 | FY11 | |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Operating income | −$131.7M | −$50.1M | −$35.9M | −$10.8M |
| Net income | −$69.4M | −$14.1M | −$36.8M | −$11.2M |
| Total assets | $103.4M | $173.4M | $96.2M | $45.1M |
| Total liabilities | $44.0M | $23.6M | $27.3M | $18.5M |
| Equity | $59.4M | $149.8M | $68.9M | −$81.0M |
| EPS (diluted) | — | — | $-4.91 | — |
| Shares out. | 21.9M | 18.3M | 18.3M | 1.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2014- Operating margin
- —
- Net margin
- —
- Return on equity
- −116.8%
- Return on assets
- −67.1%
- Return on capital (ROCE)
- −159.0%
- Liabilities / assets
- 42.5%
- Debt / equity
- 0.74×
- Book value / share
- $2.72
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2014- Altman Z″ (distress)
- -11.73distress
- Accruals / assets
- −9.6%clean
- Piotroski F-Score
- 1/7weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 1 warning● 2 good- Altman Z″ in the distress zone
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.